(0.09%) 5 474.32 points
(0.10%) 39 153 points
(0.41%) 17 790 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.78%) $2 312.70
(0.16%) $28.92
(3.44%) $1 020.30
(0.28%) $0.936
(0.70%) $10.68
(0.46%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States...
Stats | |
---|---|
今日成交量 | 31 317 |
平均成交量 | 0 |
市值 | 7.08M |
EPS | $-0.430 ( Q2 | 2022-08-12 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.60 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.366 (15.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-17 | Hardy Reginald L | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Hardy Reginald L | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Samant Vijay B | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Lyons Gary A | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Lyons Gary A | Buy | 65 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 10 056 470 | Sell: 193 721 |
音量 相关性
Brickell Biotech, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Brickell Biotech, Inc. 相关性 - 货币/商品
Brickell Biotech, Inc. 财务报表
Annual | 2021 |
营收: | $404 000 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-22.05 |
FY | 2021 |
营收: | $404 000 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-22.05 |
FY | 2020 |
营收: | $1.82M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-38.25 |
FY | 2019 |
营收: | $7.92M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-202.50 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Brickell Biotech, Inc.
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。